Bayer, Johnson and Johnson's heart drug Xarelto fails trial to widen use Ruby Khatun Khatun28 Aug 2018 9:45 AM ISTFRANKFURT: Bayer and Johnson and Johnson's campaign to widen the market for its heart drug Xarelto hit a snag on Sunday when a study for a potential...